Hanjun Kim

Title: Hanjun Kim: Innovator in Shear-Thinning Hydrogel Technology

Introduction

Hanjun Kim is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of biomaterials, particularly in the development of innovative hydrogel technologies for medical applications. His work focuses on enhancing tumor therapy through advanced materials that improve drug delivery systems.

Latest Patents

Hanjun Kim holds a patent for an "Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy." This groundbreaking invention utilizes novel shear-thinning biomaterials composed of silica nanoparticles, gelatin-based polymers, and therapeutic agents such as doxorubicin. The technology allows for the easy delivery of these materials through catheters directly into targeted areas, making it particularly useful in cancer therapy and immunotherapy. When a force above a certain threshold is applied, the material thins and behaves as a semi-solid, facilitating its flow through a catheter. Once the force is removed, the material quickly returns to a soft solid state, maintaining its cohesive properties to prevent dislodging.

Career Highlights

Throughout his career, Hanjun Kim has worked with esteemed organizations, including the Mayo Foundation for Medical Education and Research and the University of California. His experience in these institutions has allowed him to refine his expertise in biomaterials and therapeutic applications.

Collaborations

Hanjun Kim has collaborated with notable colleagues such as Chun Xu and Ehsan Jabbarzadeh. Their combined efforts have contributed to advancements in the field of biomaterials and therapeutic delivery systems.

Conclusion

Hanjun Kim's innovative work in shear-thinning hydrogel technology represents a significant advancement in medical therapies, particularly for cancer treatment. His contributions continue to influence the development of effective drug delivery systems.